Anders Lehmann

Chief Scientific Officer at Stayble Therapeutics
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
SE
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Stayble Therapeutics
    • Sweden
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Chief Scientific Officer
      • Feb 2021 - Present

    • Vice President Development
      • Sep 2015 - Feb 2021

      Gothenburg, Sweden

  • NextRx
    • Founder and owner
      • Nov 2013 - Present

  • Sahlgrenska Academy at University of Gothenburg
    • Sweden
    • Research Services
    • 400 - 500 Employee
    • Adjunct Professor of Neuroscience and Physiology
      • Sep 2012 - Present

  • Oncorena AB
    • Sweden
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Chief Operating Officer
      • Nov 2016 - Jun 2018

      Gothenburg, Sweden

  • Attenua, Inc.
    • United States
    • Pharmaceutical Manufacturing
    • Member of Scientific Advisory Board
      • Oct 2016 - Dec 2017

      New York, New York

  • AstraZeneca R&D Mölndal
    • Senior Principal Scientist
      • 2012 - Jul 2013

  • AstraZeneca R&D
    • Disease Science Director, Appetite Regulation
      • 2011 - 2012

      Mölndal, Sweden

  • AstraZeneca
    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Disease Area Portfolio Leader Appetite Regulation
      • 2008 - 2011

    • Member of a team setting up a Biotech
      • 2007 - 2008

  • AstraZeneca
    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Disease Area Scientific Leader, Gastroesophageal Reflux Disease
      • 1999 - 2006

      Mölndal

    • Associate Director
      • May 1991 - Sep 1999

Community

You need to have a working account to view this content. Click here to join now